Page last updated: 2024-12-06

3-(trimethoxysilyl)propyldimethyloctadecylammonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(trimethoxysilyl)propyldimethyloctadecylammonium: RN given refers to chloride [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID62827
CHEMBL ID2360248
SCHEMBL ID33447
MeSH IDM0069902

Synonyms (80)

Synonym
dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride
AKOS008901184
caswell no. 892b
dc 5700
quat-silsesquioxane
epa pesticide chemical code 107401
dimethyloctadecyl(3-(trimethoxysilyl)propyl)ammonium chloride
x9-5700
3-(trimethoxysilyl)propyldimethyloctadecylammonium
einecs 248-595-8
q9-5700
3-(trimethoxysilyl)propyl dimethyl octadecyl ammonium chloride
dow corning 5700
octadecyldimethyl(3-(trimethoxysilyl)propyl)ammonium chloride
1-octadecanaminium, n,n-dimethyl-n-(3-(trimethoxysilyl)propyl)-, chloride
NCGC00166112-01
27668-52-6
n,n-dimethyl-n-(3-(trimethoxysilyl)propyl) octadecan-1-aminium chloride
dtxcid2015542
tox21_112321
cas-27668-52-6
dtxsid4035542 ,
c 18ntms
dow corning 5701
ca 200
aem 5700 antimicrobial
siqac
ay 43-006
unii-iq36o85wq4
aem 5700
a 9-6346
aegis aem 5700
q 9-5700
iq36o85wq4 ,
dmoap
bioshield am 500i
(3-(trimethoxysilyl)propyl)dimethyloctadecylammonium chloride
pc 5700
dmaop
biosafe mcx 117683
1-octadecanaminium, n,n-dimethyl-n-(3-(trimethoxysilyl)propyl)-, chloride (1:1)
ls 6985
ammonium, dimethyloctadecyl(3-(trimethoxysilyl)propyl)-, chloride
goldshield 5
octadecyldimethyl(trimethoxysilyl)propylammonium chloride
5700 antimicrobial agent
monofoil antimicrobial liquid
dk-q 8-8905
(3-(trimethoxysilyl)propyl)octadecyldimethylammonium chloride
bioshield am 500
sio 6620
monofoil
n-octadecyldimethyl(3-(trimethoxysilyl)propyl)ammonium chloride
hsdb 8296
q 9-6346
polon mf 50
dow corning 9-6346
proshield 5000d
xs 70-241
agrishield
xz 2-2300
da 5700
1-octadecanaminium, n,n-dimethyl-n-(3-(trimethoxysilyl) propyl)-, chloride
SCHEMBL33447
dimethyl-n-octadecyl [3(trimethoxysilyl)propyl]ammonium chloride
WSFMFXQNYPNYGG-UHFFFAOYSA-M
dimethyl-n-octadecyl [3(trimethoxysilyl)propyl] ammonium chloride
n,n-dimethyl-n-(3-(trimethoxysilyl)propyl)octadecan-1-aminium chloride
3-(TRIMETHOXYSILYL)PROPYLDIMETHYLOCTODECYL-AMMONIUM CHLORIDE ,
CHEMBL2360248
FT-0698152
dimethyl(octadecyl)[3-(trimethoxysilyl)propyl]azanium chloride
3-(trimethoxysilyl)-propyldimethyloctadecyl ammonium chloride
octadecyldimethyl(3-trimethoxysilylpropyl) ammonium chloride, 60% in methanol
dimethyl-octadecyl-(3-trimethoxysilylpropyl)azanium;chloride
mfcd00054224
octadecyldimethyl (3-trimethoxysilylpropyl) ammonium chloride
Q27280845
[3-(trimethoxysilyl)propyl]octadecyldimethylammonium chloride
D87857

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Using these hepatic changes as an adverse effect, the maternal no observable adverse effect level for this study was identified at 300 mg/kg/day."( Quaternary silsesquioxane: a developmental toxicity study in rats.
Siddiqui, WH; York, RG, 1993
)
0.29
" The QAS copolymers were less toxic to 3 human cell lines than a commercial antimicrobial QAS monomeric agent, namely, dimethyloctadecyl[3-(trimethoxysilyl) propyl]ammonium chloride (DTPAC)."( High durability and low toxicity antimicrobial coatings fabricated by quaternary ammonium silane copolymers.
Bao, H; Bok, KX; Kang, L; Lee, CY; Li, B; Li, H; Zin, MT, 2016
)
0.43

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency17.80030.000811.382244.6684AID686978; AID686979
estrogen nuclear receptor alphaHomo sapiens (human)Potency18.22420.000229.305416,493.5996AID743075; AID743077; AID743079
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.54)18.7374
1990's2 (7.69)18.2507
2000's8 (30.77)29.6817
2010's11 (42.31)24.3611
2020's2 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.52 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.85%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]